The stock of Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) registered a decrease of 4.74% in short interest. BLPH’s total short interest was 26,100 shares in April as published by FINRA. Its down 4.74% from 27,400 shares, reported previously. With 15,000 shares average volume, it will take short sellers 2 days to cover their BLPH’s short positions. The short interest to Bellerophon Therapeutics Incorporated’s float is 0.64%. The stock increased 7.01% or $0.15 on April 6, hitting $2.29. About 13,660 shares traded hands. Bellerophon Therapeutics Inc (NASDAQ:BLPH) has declined 57.37% since August 28, 2015 and is downtrending. It has underperformed by 60.20% the S&P500.
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The company has a market cap of $29.75 million. The Firm is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary and cardiac diseases. It currently has negative earnings. The Firm has two programs in development.
Bellerophon Therapeutics Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.